MDR1 diplotypes as prognostic markers in multiple myeloma

Pharmacogenetics and Genomics
Valentina MagginiAnna Maria Rossi

Abstract

The aim of this study was to evaluate the effect of diplotypes of MDR1 polymorphisms at positions 2677 and 3435 on the clinical outcome of multiple myeloma, in terms of response to the therapy and overall survival (OS). G2677T/A SNP was analysed by RFLP-PCR assay on 110 patients, treated with dexamethasone, doxorubicin (adryamicin) and vincristine regimen, followed by autologous stem cell transplantation. Treatment efficacy was not related to G2677T/A SNP, whereas the OS of G/G carriers was significantly shorter than that of T/T or G/T patients. Similar results were previously reported for MDR1 C3435T polymorphism. Given that these two single nucleotide polymorphisms are in strong linkage disequilibrium, we analyzed the effects of the most frequent haplo/diplotypes and the survival probability was lower for GC/GC patients (55%) than for GC/TT and TT/TT carriers (>80%; log-rank test, P=0.03). Interestingly, the effect of MDR1 diplotype on the OS seems to be confined to autologous stem cell transplantation nonresponders. These results support the hypothesis that genetic variability of MDR1 should be considered as an important factor that influences the clinical outcome of multiple myeloma.

References

Jul 15, 1989·Annals of Internal Medicine·E Kahn, G Letz
Jan 19, 2000·Trends in Biochemical Sciences·R W JohnstoneM J Smyth
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
Nov 12, 2002·Clinical Pharmacology and Therapeutics·Andreas JohneIvar Roots
Jan 30, 2004·Clinical Pharmacology and Therapeutics·Catia MarzoliniRichard B Kim
Feb 21, 2004·Human Molecular Genetics·Kun TangCaroline G L Lee
Jul 27, 2005·British Journal of Clinical Pharmacology·Balram ChowbayEdmund J D Lee
Sep 6, 2005·Pharmacogenetics and Genomics·Danxin WangWolfgang Sadée
Feb 24, 2006·Journal of Clinical Pharmacology·Pengfei SongCharles R Yates
Nov 23, 2006·Clinical Pharmacology and Therapeutics·Bronno van der HoltPieter Sonneveld
Dec 23, 2006·Science·Chava Kimchi-SarfatyMichael M Gottesman
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michele CavoMichele Baccarani
May 10, 2007·British Journal of Haematology·Gabriele BudaMario Petrini

❮ Previous
Next ❯

Citations

Feb 9, 2011·Nature Reviews. Genetics·Ryan TewheyNicholas J Schork
Apr 17, 2013·The Pharmacogenomics Journal·F AminkengUNKNOWN Canadian Pharmacogenomics Network for Drug Safety Consortium
Jul 10, 2010·Leukemia & Lymphoma·Stephen DrainH Denis Alexander
Apr 18, 2009·Leukemia & Lymphoma·Deborah Rund
Apr 18, 2009·Leukemia & Lymphoma·Stephen DrainH Denis Alexander
Aug 13, 2015·International Journal of Molecular Sciences·Vittorio SimeonPellegrino Musto
Sep 17, 2011·Expert Opinion on Drug Metabolism & Toxicology·David Jamieson, Alan V Boddy
Jan 23, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Guangli YinKourong Miao
May 30, 2009·Chemistry & Biodiversity·Bernard Testa, Stefanie D Krämer
Sep 3, 2011·European Journal of Haematology·Annette VangstedUlla Vogel
Jun 28, 2011·Leukemia Research·Stephen DrainH Denis Alexander
Sep 17, 2020·Clinical and Translational Science·Pablo ZubiaurFrancisco Abad-Santos
May 14, 2016·International Journal of Oncology·Sabna Rajeev KrishnanMary Bebawy
Sep 10, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhengrui XiaoKourong Miao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.